The role of interventional molecular epidemiology in controlling clonal clusters of multidrug resistant Pseudomonas aeruginosa in critically ill cancer patients

American Journal of Infection Control

Volumn 37, Issue 6, 2009, Pages 442-446

  Adachi, Javier A ^a   Perego, Cheryl ^a   Graviss, Linda ^a   Dvorak, Tanya ^a   Hachem, Ray ^a   Chemaly, Roy F ^a   Raad, Issam I ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEFEPIME; CEFTAZIDIME; CIPROFLOXACIN; COLISTIN; IMIPENEM; LEVOFLOXACIN; MEROPENEM; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BACTERIAL TRANSMISSION; BACTERIUM IDENTIFICATION; CANCER PATIENT; CLONING; CRITICAL ILLNESS; EPIDEMIC; HOSPITAL INFECTION; HUMAN; IN VITRO STUDY; INFECTION CONTROL; INTENSIVE CARE UNIT; MOLECULAR EPIDEMIOLOGY; MONITORING; MULTIDRUG RESISTANCE; NONHUMAN; PSEUDOMONAS AERUGINOSA; PULSED FIELD GEL ELECTROPHORESIS;

ANTI-BACTERIAL AGENTS; BACTERIAL TYPING TECHNIQUES; CLUSTER ANALYSIS; CRITICAL ILLNESS; CROSS INFECTION; DISEASE OUTBREAKS; DNA FINGERPRINTING; DNA, BACTERIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; EPIDEMIOLOGY, MOLECULAR; GENOTYPE; HUMANS; INFECTION CONTROL; MICROBIAL SENSITIVITY TESTS; NEOPLASMS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS;

EID: 67651021116     PISSN: 01966553     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajic.2008.09.012     Document Type: Article

References (38)

1. Bukholm G., Tannaes T., Kjelsberg A.B., and Smith-Erichsen N. An outbreak of multidrug-resistant Pseudomonas aeruginosa associated with increased risk of patient death in an intensive care unit. Infect Control Hosp Epidemiol 23 (2002) 441-446
2. Carmeli Y., Triollet N., Karchmer A., and Samore M.H. Health and economic outcomes of antibiotic resistance in Pseudomonas aeruginosa. Arch Intern Med 159 (1999) 1127-1132
3. Cortes P., Mariscal D., Valles J., Rello J., and Coll P. Presence of polyclonal Pseudomonas aeruginosa in an intensive care unit: a 27-month prospective study on molecular epidemiology. Infect Control Hosp Epidemiol 22 (2001) 720-723
4. Gales A.C., Jones R.N., Turnidge J., Rennie R., and Ramphal R. Characterization of Pseudomonas aeruginosa isolates: occurrence rates, antimicrobial susceptibility patterns, and molecular typing in the global SENTRY Antimicrobial Surveillance Program, 1997-1999. Clin Infect Dis 32 Suppl 2 (2001) S146-55
5. Harris A., Torres-Viera C., Venkataraman L., DeGirolami P., Samore M., and Carmei Y. Epidemiology and clinical outcomes of patients with multiresistant Pseudomonas aeruginosa. Clin Infect Dis 28 (1999) 1128-1133
6. Livermore D.M. Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare?. Clin Infect Dis 34 (2002) 634-640
7. Paterson D.L. The epidemiological profile of infections with multidrug-resistant Pseudomonas aeruginosa and Acinetobacter species. Clin Infect Dis 43 Suppl 2 (2006) S43-S48
8. Talon D., Mulin B., Rouget C., Bailly P., Thouverez M., and Viel J.-F. Risks and routes for ventilator-associated pneumonia with Pseudomonas aeruginosa. Am J Respir Crit Care Med 157 (1998) 978-984
9. Aloush V., Navon-Venezia S., Seigman-Igra Y., Cabili S., and Carmeli Y. Multidrug-resistant Pseudomonas aeruginosa: risk factors and clinical impact. Antimicrob Agent Chemother 50 (2006) 43-48
10. Elting L.S., Rubenstein E.B., Rolston K.V., and Bodey G.P. Outcomes of bacteremia in patients with cancer and neutropenia: observations from two decades of epidemiological and clinical trials. Clin Infect Dis 2 (1997) 247-259
11. National Nosocomial Infections Surveillance System. National Nosocomial Infections Surveillance System report, data summary from January 1992 to June 2002, issued August 2002. Am J Infect Control 30 (2002) 458-475
12. Ohmagari N., Hanna H., Graviss L., Hackett B., Perego C., Gonzalez V., et al. Risk factors for infections with multidrug-resistant Pseudomonas aeruginosa in patients with cancer. Cancer 104 (2005) 205-212
13. Rossello J., Olona M., Campins M., del Valle O., Bermejo B., Armandans L., et al. Investigation of an outbreak of nosocomial infection due to a multiply drug-resistant strain of Pseudomonas aeruginosa. J Hosp Infect 20 (1992) 87-96
14. Sanders C.C., and Sanders Jr. W.E. Beta-lactam resistance in gram-negative bacteria: global trends and clinical impact. Clin Infect Dis 15 (1992) 824-839
15. Bennett J.V. Session 1. Hospital-acquired infections and the altered host: nosocomial infections due to Pseudomonas. J Infect Dis 130 Suppl (1974) S4-S7
16. Bodey G.P., Bolivar R., Fainstein V., and Jadeja L. Infections caused by Pseudomonas aeruginosa. Rev Infect Dis 5 (1983) 279-313
17. Whitecar J.P., Luna M., and Bodey G.P. Pseudomonas bacteremia in patients with malignant diseases. Am J Med Sci 260 (1970) 216-223
18. Talbot G.H., Bradley J., Edwards Jr. J.E., Gilbert D., Scheld M., and Barlett J.G. Bad bugs need drugs: an update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America. Clin Infect Dis 42 (2006) 657-668
19. Deplano A., Denis O., Poirel L., Hocquet D., Nonhoff C., Byl B., et al. Molecular characterization of an epidemic clone of panantibiotic-resistant Pseudomonas aeruginosa. J Clin Microbiol 43 (2005) 1198-1204
20. Paterson D.L. Looking for risk factors for the acquisition of antibiotic resistance: a 21st-century approach. Clin Infect Dis 34 (2002) 1564-1567
21. Sader H., Pignatari A.C., Leme I.L., Burattini M.N., Tancresi R., Hollis R.J., et al. Epidemiologic typing of multiple drug-resistant Pseudomonas aeruginosa isolated from an outbreak in an intensive care unit. Diagn Microbiol Infect Dis 17 (1993) 13-18
22. Speijer H., Savelkoul P.H., Bonten M.J., Stobberingh E.E., and Tjhie J.H. Application of different genotyping methods for Pseudomonas aeruginosa in a setting of endemicity in an intensive care unit. J Clin Microbiol 37 (1999) 3654-3661
23. Talon D., Cailleaux V., Thouverez M., and Michel-Briand Y. Discriminatory power and usefulness of pulsed-field gel electrophoresis in epidemiological studies of Pseudomonas aeruginosa. J Hosp Infect 32 (1996) 135-145
24. Garner J.S., Jarvis W.R., Emori T.G., Horan T.C., and Hughes J.M. CDC definition for nosocomial infections. In: Olmstead R.N. (Ed). Infection control and applied epidemiology: principles and practice (1996), Mosby, St. Louis
25. National Committee for Clinical Laboratory Standards (NCCLS), currently the Clinical and Laboratory Standards Institute (CLSI). Methods for dilution antimicrobial susceptibility test for bacteria that grow aerobically, 5th ed. Approved standard M7-A5. Wayne: National Committee for Clinical Laboratory Standards; 2002.
26. Finney M. Pulsed-field gel electrophoresis. In: Anusubel F.M., Brent R., Kingston R.E., Moore D.D., Seidman J.G., Smith J.A., and Struhl K. (Eds). Current protocols in molecular biology, vol. 1. Current protocols (1993), Greene-Wiley, New York 2.5.9-2.5.17
27. Tenover F.C., Arbeit R.D., Goering R.V., Mickelsen P.A., Murray B.E., Persing D.H., et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 33 (1995) 2233-2239
28. Hocquet D., Bertrand X., Kohler T., Talon D., and Plesiat P. Genetic and phenotypic variations of a resistant Pseudomonas aeruginosa epidemic clone. Antimicrob Agent Chemother 47 (2003) 1887-1894
29. Murray S.A., and Snydman D.R. Investigation of an epidemic of multidrug-resistant Pseudomonas aeruginosa. Infect Control 3 (1982) 456-460
30. Paramythiotou E., Lucet J.C., Timsit J.-F., Vanjack D., Paugam-Burtz C., Trouillet J.L., et al. Acquisition of multidrug-resistant Pseudomonas aeruginosa in patients in intensive care units: role of antibiotics with antipseudomonal activity. Clin Infect Dis 38 (2004) 670-677
31. El Amari E.B., Chamot E., Auckenthaler R., Pechere J.C., and Van Delden C. Influence of previous exposure to antibiotic therapy on the susceptibility pattern of Pseudomonas aeruginosa bacteremic isolates. Clin Infect Dis 33 (2001) 1859-1864
32. Rello J., Ausina V., Ricart M., Puzo C., Quintana E., Net A., et al. Risk factors for infection by Pseudomonas aeruginosa in patients with ventilator-associated pneumonia. Intensive Care Med 20 (1994) 193-198
33. Doebbeling B.N., Pfaller M.A., Houston A.K., and Wenzel R.P. Removal of nosocomial pathogens from the contaminated glove: implications for glove reuse and handwashing. Ann Intern Med 109 (1988) 394-398
34. McNeil S.A., Nordstrom-Lerner L., Malani P.N., Zervos M., and Kauffman C.A. Outbreak of sternal surgical site infections due to Pseudomonas aeruginosa traced to a scrub nurse with onychomycosis. Clin Infect Dis 33 (2001) 317-323
35. Moolenaar R.L., Crutcher J.M., San Joaquin V.H., Sewell L.V., Hutwagner L.C., Carson L.A., et al. A prolonged outbreak of Pseudomonas aeruginosa in a neonatal intensive care unit: did staff fingernails play a role in disease transmission?. Infect Control Hosp Epidemiol 21 (2000) 80-85
36. Trautmann M., Michalsky T., Wiedeck H., Radosavljevic V., and Ruhnke M. Tap water colonization with Pseudomonas aeruginosa in a surgical intensive care unit (ICU) and relation to Pseudomonas infections of ICU patients. Infect Control Hosp Epidemiol 22 (2001) 49-52
37. Widmer A.F., Wenzel R.P., Trilla A., Bale M.J., Jones R.N., and Doebbeling B.N. Outbreak of Pseudomonas aeruginosa infections in a surgical intensive care unit: probable transmission via hands of a health care worker. Clin Infect Dis 16 (1993) 372-376
38. Harris A.D., McGregor J.C., and Furuno J.P. What infection control interventions should be undertaken to control multidrug-resistant gram-negative bacteria?. Clin Infect Dis 43 Suppl 2 (2006) S57-S61